GN Store Nord A/S
OTC:GGNDF

Watchlist Manager
GN Store Nord A/S Logo
GN Store Nord A/S
OTC:GGNDF
Watchlist
Price: 16.41 USD Market Closed
Market Cap: $2.4B

P/OCF

5.3
Current
35%
Cheaper
vs 3-y average of 8.2

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
5.3
=
Market Cap
$13.3B
/
Operating Cash Flow
kr2.7B

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
5.3
=
Market Cap
$13.3B
/
Operating Cash Flow
kr2.7B

Valuation Scenarios

GN Store Nord A/S is trading below its 3-year average

If P/OCF returns to its 3-Year Average (8.2), the stock would be worth $25.38 (55% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+183%
Average Upside
116%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 5.3 $16.41
0%
3-Year Average 8.2 $25.38
+55%
5-Year Average 15 $46.4
+183%
Industry Average 11.6 $36.12
+120%
Country Average 10.9 $33.91
+107%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
DK
GN Store Nord A/S
OTC:GGNDF
14.3B USD 5.3 21.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
167.2B USD 55.2 58.6
US
Abbott Laboratories
NYSE:ABT
161.2B USD 16.8 25.7
US
Stryker Corp
NYSE:SYK
125.8B USD 24.9 38.8
IE
Medtronic PLC
NYSE:MDT
106.4B USD 14.6 23.1
US
Boston Scientific Corp
NYSE:BSX
88.9B USD 19.6 24.9
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD 30.4 44.2
DE
Siemens Healthineers AG
XETRA:SHL
40.1B EUR 13.1 18.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.8B USD 38.8 43.3
US
Becton Dickinson and Co
NYSE:BDX
42.8B USD 12.6 24.3
US
Resmed Inc
NYSE:RMD
32.3B USD 16.9 21.8

Market Distribution

Lower than 100% of companies in Denmark
Percentile
0th
Based on 393 companies
0th percentile
0.9
Low
1.1 — 7.9
Typical Range
7.9 — 18.5
High
18.5 —
Distribution Statistics
Denmark
Min 1.1
30th Percentile 7.9
Median 10.9
70th Percentile 18.5
Max 4 450

GN Store Nord A/S
Glance View

Market Cap
2.4B USD
Industry
Health Care

In the bustling world of global technology, GN Store Nord A/S stands out as a fascinating player with a legacy dating back to 1869. Originally rooted in the telegraph industry, the company has adeptly metamorphosed through time to become a leader in hearing aids and audio devices. The heart of GN Store Nord's business beats in its dual prowess: GN Hearing and GN Audio. These twin pillars allow the company to seamlessly blend healthcare innovation with cutting-edge consumer technology. GN Hearing focuses on the development and production of advanced hearing aid solutions, catering to the growing demographic of individuals seeking quality life enhancements through better hearing. By leveraging sophisticated technologies, such as artificial intelligence and wireless connectivity, GN Hearing offers a range of products that improve the auditory experience for users worldwide. Parallelly, GN Audio operates under the brand Jabra, where it crafts a variety of audio and video solutions that cater to both professional and personal needs. From state-of-the-art headsets used in corporate environments to immersive earbuds favored by audiophiles, GN Audio has carved a significant niche for itself in the audio market. The synergy between GN's hearing and audio segments not only fuels revenue generation but also sustains its commitment to innovation, allowing the company to adapt and thrive in an ever-evolving technological landscape. By tapping into the demand for superior audio and communication devices, GN Store Nord maintains a robust financial performance while continuously exploring new growth avenues within its core sectors.

GGNDF Intrinsic Value
22.73 USD
Undervaluation 28%
Intrinsic Value
Price $16.41
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett